Kitazono et al. reported that sodium butyrate, a differentiation-inducing agent, can increase the levels of expression of LRP mRNA and LRP and confer resistance to adriamycin (ADM) and VP-16 in a human colon carcinoma cell line. The gene discussed is MVP; the disease is colon carcinoma.